세계 유전자 발현 분석 시장 : 제품(시약, 효소, 키트, DNA 칩, PCR, NGS, DNA 마이크로어레이), 서비스(RNA 시퀀싱, 생물 정보학), 용도(창약 개발, 임상 진단) 예측(-2029년)

Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User - Global Forecast to 2029

US $ 4,950 ￦ 7,344,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,866,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 12,092,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,837,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

유전자 발현 분석 시장 규모는 예측 기간 동안 복합 연간 성장률(CAGR) 8.1%를 나타낼 전망이며 2024년 42억 달러에서 2029년에는 62억 달러 규모에 달할 것으로 예측됩니다.

조사 범위
조사 대상년도	2022-2029년
기준년	2023년
예측 기간	2024-2029년
단위	금액(달러)
부문	제품, 서비스, 용도, 최종 사용자
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 & 아프리카

이 시장의 성장은 유전체학 연구에 대한 투자가 증가하고 있기 때문에 유전학적 연구를 위해 정부로부터의 자금 지원을 받는 것도 시장 확대에 기여하고 있습니다. 유전자 발현 분석 분야는 유전자 조절과 분자 메커니즘의 이해를 깊게 하면서 진화를 계속하고 있으며, 유전자 발현 분석 시장은 지속적인 성장과 혁신이 예상되고 있습니다.

장비별로 PCR 장비 부서는 2023년 최대 점유율을 차지합니다.

2023년 세계 유전자 발현 분석 시장에서 PCR 기기가 제품&서비스 기기의 하위 구분에서 가장 큰 점유율을 보였습니다. PCR 장비는 제약, 생명 공학, 학술 연구, 임상 진단, 법의학을 포함한 다양한 산업에서 널리 채택됩니다. 이 광범위한 적용 범위는 PCR 장비의 큰 시장 점유율에 기여합니다.

아시아태평양은 예측 기간 동안 유전자 발현 분석 시장에서 가장 높은 복합 연간 성장률(CAGR)을 나타낼 전망 :

아시아태평양은 예측 기간 동안 가장 높은 성장률로 성장할 것으로 예측됩니다. 이 지역은 단백질체학와 유전체학 연구의 확대, 연구 자금의 증강, 제약 기업 및 생명 공학 기업으로부터의 투자 확대, 맞춤형 치료를 둘러싼 의식의 높아짐에 추진되어 급속한 성장이 전망되고 있습니다. 아시아태평양에서는 가격과 진단의 이점에 대한 의식이 높아지면서 특히 인도와 중국이 가장 높은 성장을 보일 것으로 예상됩니다.

본 보고서에서는 세계 유전자 발현 분석 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술,특허 동향, 법규제 환경, 시장 규모 추이와 예측, 각종 구분, 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회
  • 과제
• 고객의 비즈니스에 영향을 미치는 동향/혁신
• 가격 분석
• 밸류체인 분석
• 공급망 분석
• 생태계 분석
• 기술 분석
• 특허 분석
• 무역 데이터
• 주요 회의 및 이벤트
• 규제 상황
• Porter's Five Forces 분석
• 주요 이해관계자와 구매 기준

제6장 유전자 발현 분석 시장 : 제품?서비스별

• 시약 및 소모품
  • 어세이 및 키트
  • 효소
  • DNA 칩
  • 기타
• 기기
  • PCR
  • NGS
  • DNA 마이크로어레이
  • 기타
• 서비스
  • 유전자 발현 분석 서비스
  • 바이오인포매틱스 솔루션

제7장 유전자 발현 분석 시장 : 용도별

• 창약?개발
• 임상 진단
• 기타

제8장 유전자 발현 분석 시장 : 최종 사용자별

• 제약,바이오테크놀러지 기업
• 학술연구기관
• 기타

제9장 유전자 발현 분석 시장 :지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제10장 경쟁 구도

• 주요 기업의 채용 접근
• 수익 점유율 분석
• 시장 점유율 분석
• 기업 평가 매트릭스 : 주요 기업
• 기업평가 매트릭스: 신흥기업/중소기업
• 신흥기업/중소기업 경쟁 벤치마킹
• 유전자 발현 분석 벤더의 평가와 재무 지표
• 브랜드/제품 비교 분석
• 경쟁 시나리오

제11장 기업 프로파일

• 주요 기업
  • THERMO FISHER SCIENTIFIC INC.
  • BIO-RAD LABORATORIES, INC.
  • ILLUMINA, INC.
  • QIAGEN
  • F. HOFFMANN-LA ROCHE LTD.
  • REVVITY
  • PACBIO
  • AGILENT TECHNOLOGIES, INC.
  • SYSMEX CORPORATION
  • BGI
  • EUROFINS SCIENTIFIC SE
  • STANDARD BIOTOOLS
  • OXFORD NANOPORE TECHNOLOGIES PLC
  • GENSCRIPT
  • TAKARA BIO INC.
• 기타 기업
  • 10X GENOMICS INC.
  • ZYMO RESEARCH CORPORATION
  • TWIST BIOSCIENCE
  • PROMEGA CORPORATION
  • LGC LIMITED
  • CD GENOMICS
  • NANOSTRING TECHNOLOGIES, INC.
  • BIOSPYDER, INC
  • INTEGRATED DNA TECHNOLOGIES, INC.
  • NEW ENGLAND BIOLABS, INC.

제12장 부록

BJH

영문 목차

영문목차

The gene expression analysis market is projected to reach USD 6.2 billion by 2029 from an estimated USD 4.2 billion in 2024, at a CAGR of 8.1% during the forecast period.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD) Billion
Segments	Product & Service, Application, and End User
Regions covered	North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

The growth of this market can be attributed to the growing investments in genomics research and the availability of government funding for genetic studies further contributes to the market's expansion. As the field continues to evolve, with a deeper understanding of gene regulation and molecular mechanisms, the gene expression analysis market is poised for continued growth and innovation.

"The PCR instrument segment accounted for the largest share by instruments in 2023."

In 2023, the PCR segment accounted for the largest share of instruments sub-segment of product & service in the global gene expression analysis market. PCR instruments are widely adopted across various industries, including pharmaceuticals, biotechnology, academic research, clinical diagnostics, and forensic sciences. This broad application range contributes to the substantial market share of PCR instruments.

"The Asia Pacific region is grows at the highest CAGR in the gene expression analysis market during the forecast period of 2024-2029."

The Asia Pacific region is expected to grow at the highest growth rate during the forecast period. This region is s anticipated to experience rapid growth, fueled by expanding proteomics and genomics research, augmented research funding, amplified investments from pharmaceutical and biotechnology enterprises, and rising awareness surrounding personalized therapeutics. India and China are expected to display the highest growth in the Asia Pacific region, particularly due to the rise in affordability and awareness related to the benefits of diagnosis.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers - 45%, CXOs and Directors - 30%, and Executives- 25%
• By Region: North America -45%, Europe -20%, Asia-Pacific -20%, Latin America -10%, Middle East & Africa- 5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc (US)
• Bio-Rad Laboratories Inc. (US)
• Illumina Inc (US)
• QIAGEN (Netherlands)
• F. Hoffmann-La Roche (Switzerland)
• Revvity (US)
• PacBio (US)
• Agilent Technologies Inc (US)
• Oxford Gene Technology IP Limited (UK)
• BGI (China)
• Eurofins Scientific (Luxembourg)
• Standard BioTools (US)
• Oxford Nanopore Technologies plc (UK)
• GenScript (US)
• Takara Bio Inc (Japan)
• 10x Genomics (US)
• Zymo Research Corporation (US)
• Twist Bioscience (US)
• Promega Corporation (US)
• LGC Limited (UK)
• CD Genomics (US)
• NanoString Technologies Inc. (US)
• BioSpyder, Inc (US)
• Integrated DNA Technologies, Inc (US)
• New England Biolabs (US).

Research Coverage:

This research report categorizes the gene expression analysis market by product & service (instruments, reagents & consumables and services (gene expression analysis service and bioinformatics service)), application (clinical diagnostics, drug discovery & development, and other applications (developmental biology, pharmacogenomics, environmental response, forensic research, agricultural research)) , end user (pharmaceutical & biotechnology companies, academic & research institutes, and other end users (clinical laboratories, CROs, forensic laboratories, agricultural & environmental organizations)), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and trends influencing the growth of the gene expression analysis market. The report conducts in-depth analysis of major industry players, offering insights into their business profiles, product/service offerings, and strategic initiatives including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments within the gene expression analysis market. Furthermore, it encompasses competitive analysis of leading players as well as emerging startups within the gene expression analysis market ecosystem.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall gene expression analysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Advancement in gene editing technologies, increasing funding initiatives for genomic research, growing preference for therapeutic application, declining sequencing cost), restraints (high cost of instruments & consumables, concerns associated with data privacy and security), opportunities (application expansion across non-medical fields, machine learning and ai, growing focus on single-cell analysis), and challenges (prolonged timelines for approval, data interpretation challenges) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the gene expression analysis market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the gene expression analysis market
• Competitive Assessment: Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories Inc. (US), Illumina Inc (US), QIAGEN (Netherlands), F. Hoffmann-La Roche (Switzerland), Revvity (US), PacBio (US), Agilent Technologies Inc (US), Oxford Gene Technology IP Limited (UK), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc (Japan), 10x Genomics (US), Zymo Research Corporation (US), Twist Bioscience (US), Promega Corporation (US), LGC Limited (UK), CD Genomics (US), NanoString Technologies Inc. (US), BioSpyder, Inc (US), Integrated DNA Technologies, Inc (US) and New England Biolabs (US), among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 REGIONS COVERED
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 RESEARCH LIMITATIONS
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
• 1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 GENE EXPRESSION ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 3 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023
  • 2.2.1 INSIGHTS FROM PRIMARIES
  • FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
  • 2.2.2 SEGMENT ASSESSMENT (BY PRODUCT & SERVICE, APPLICATION, AND END USER)
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• 2.3 GROWTH RATE ASSUMPTIONS
  • FIGURE 8 GENE EXPRESSION ANALYSIS MARKET: CAGR PROJECTIONS (2024-2029)
  • FIGURE 9 GENE EXPRESSION ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
• 2.5 STUDY ASSUMPTIONS
• 2.6 RISK ANALYSIS
• 2.7 RECESSION IMPACT ANALYSIS
  • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024-2028 (% GROWTH)
  • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
  • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

• FIGURE 11 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION)
• FIGURE 12 GENE EXPRESSION SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 GEOGRAPHIC SNAPSHOT OF GENE EXPRESSION ANALYSIS MARKET

4 PREMIUM INSIGHTS

• 4.1 GENE EXPRESSION ANALYSIS MARKET OVERVIEW
  • FIGURE 16 ADVANCEMENTS IN GENE EDITING TECHNOLOGIES TO DRIVE MARKET
• 4.2 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023
  • FIGURE 17 PRODUCT & SERVICE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
• 4.3 GENE EXPRESSION ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE, 2024 VS. 2029
  • FIGURE 18 PRODUCT & SERVICE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• 4.4 GENE EXPRESSION ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 20 GENE EXPRESSION ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Advancements in gene editing technologies
    • 5.2.1.2 Increasing funding initiatives for genomic research
    • 5.2.1.3 Growing preference for therapeutic applications
    • 5.2.1.4 Declining costs of sequencing technologies
  • FIGURE 21 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001-2022
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of instruments & consumables
    • 5.2.2.2 Concerns associated with data privacy and security
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 High growth potential across non-clinical applications
    • 5.2.3.2 Machine learning and AI
    • 5.2.3.3 Growing focus on single-cell analysis
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Extensive timelines for product approval
    • 5.2.4.2 Data interpretation challenges
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 22 REVENUE SHIFT TOWARDS GENE EXPRESSION ANALYSIS COMPANIES
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
  • TABLE 4 GENE EXPRESSION ANALYSIS PRODUCT PRICE
• 5.5 VALUE CHAIN ANALYSIS
  • FIGURE 23 GENE EXPRESSION ANALYSIS MARKET: VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
  • FIGURE 24 GENE EXPRESSION ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS
  • TABLE 5 GENE EXPRESSION ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
  • FIGURE 25 GENE EXPRESSION ANALYSIS MARKET ECOSYSTEM
  • 5.7.1 GENE EXPRESSION ANALYSIS MARKET: REAGENT & CONSUMABLE VENDORS
  • TABLE 6 GENE EXPRESSION ANALYSIS MARKET: REAGENT & CONSUMABLE VENDORS
  • 5.7.2 GENE EXPRESSION ANALYSIS MARKET: INSTRUMENT VENDORS
  • TABLE 7 GENE EXPRESSION ANALYSIS MARKET: INSTRUMENT VENDORS
  • 5.7.3 GENE EXPRESSION ANALYSIS MARKET: END USERS
  • TABLE 8 GENE EXPRESSION ANALYSIS MARKET: END USERS
  • 5.7.4 GENE EXPRESSION ANALYSIS MARKET: REGULATORY BODIES
  • TABLE 9 GENE EXPRESSION ANALYSIS MARKET: REGULATORY BODIES
• 5.8 TECHNOLOGY ANALYSIS
• 5.9 PATENT ANALYSIS
  • 5.9.1 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
  • TABLE 10 PATENTS FILED, 2014-2024
  • 5.9.2 INNOVATION & PATENT APPLICATIONS
  • FIGURE 26 TOTAL NUMBER OF PATENTS GRANTED, 2014-2023
  • 5.9.3 TOP APPLICANTS
  • FIGURE 27 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2024
  • FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014-2024
  • TABLE 11 TOP 12 PATENT OWNERS IN GENE EXPRESSION ANALYSIS MARKET, 2014-2024
  • TABLE 12 PATENTS IN GENE EXPRESSION ANALYSIS MARKET (2024)
• 5.10 TRADE DATA
  • 5.10.1 INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS
  • TABLE 13 IMPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018-2022 (TONS)
  • TABLE 14 EXPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018-2022 (TONS)
  • 5.10.2 MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS
  • TABLE 15 IMPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018-2022 (TONS)
  • TABLE 16 EXPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018-2022 (TONS)
• 5.11 KEY CONFERENCES & EVENTS
  • 5.11.1 GENE EXPRESSION ANALYSIS MARKET: CONFERENCES & EVENTS IN 2024-2025
  • TABLE 17 GENE EXPRESSION ANALYSIS MARKET: CONFERENCES & EVENTS (2024-2025)
• 5.12 REGULATORY LANDSCAPE
  • 5.12.1 CBER REGULATIONS ON GENE EXPRESSION ANALYSIS
  • 5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.13 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 22 GENE EXPRESSION ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.13.1 THREAT OF NEW ENTRANTS
  • 5.13.2 THREAT OF SUBSTITUTES
  • 5.13.3 BARGAINING POWER OF BUYERS
  • 5.13.4 BARGAINING POWER OF SUPPLIERS
  • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GENE EXPRESSION ANALYSIS PRODUCTS & SERVICES
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS
  • 5.14.2 BUYING CRITERIA FOR GENE EXPRESSION ANALYSIS PRODUCTS
  • FIGURE 30 KEY BUYING CRITERIA FOR END USERS
  • TABLE 24 KEY BUYING CRITERIA FOR TOP FOUR END USERS

6 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE

• 6.1 INTRODUCTION
  • TABLE 25 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• 6.2 REAGENTS & CONSUMABLES
  • TABLE 26 GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 27 GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 28 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 33 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.1 ASSAYS & KITS
    • 6.2.1.1 Growing demand for streamlined and user-friendly solutions to drive market
  • TABLE 34 GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 35 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.2 ENZYMES
    • 6.2.2.1 High uptake in molecular techniques to drive market
  • TABLE 41 GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 42 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 47 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.3 DNA CHIPS
    • 6.2.3.1 Rising demand across forensic research applications to propel market
  • TABLE 48 GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 54 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.2.4 OTHER REAGENTS & CONSUMABLES
  • TABLE 55 GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 61 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.3 INSTRUMENTS
  • TABLE 62 GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 63 GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 64 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 69 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.1 PCR
    • 6.3.1.1 Growing focus on development of novel PCR kits to boost demand
  • TABLE 70 GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 71 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 76 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.2 NGS
    • 6.3.2.1 Increasing investments in advanced technologies to drive market
  • TABLE 77 GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 78 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 81 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 83 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.3 DNA MICROARRAYS
    • 6.3.3.1 High-throughput capabilities to propel market
  • TABLE 84 GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 85 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 88 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY REGION 2022-2029 (USD MILLION)
  • TABLE 90 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3.4 OTHER INSTRUMENTS
  • TABLE 91 GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 95 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 97 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
• 6.4 SERVICES
  • TABLE 98 GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 105 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4.1 GENE EXPRESSION ANALYSIS SERVICES
  • TABLE 106 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • 6.4.1.1 RNA sequencing services
      • 6.4.1.1.1 Rising technological advancements for drug discovery development to propel market
  • TABLE 107 GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 108 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 113 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.4.1.2 Other services
  • TABLE 114 GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 115 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 119 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 120 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4.2 BIOINFORMATICS SOLUTIONS
    • 6.4.2.1 Increasing demand for advanced data analytics to support market growth
  • TABLE 121 GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 126 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 127 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)

7 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • TABLE 128 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• 7.2 DRUG DISCOVERY & DEVELOPMENT
  • 7.2.1 INCREASING INVESTMENTS IN RNA-BASED THERAPEUTICS TO PROPEL MARKET
  • TABLE 129 GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 131 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 134 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 135 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.3 CLINICAL DIAGNOSTICS
  • 7.3.1 RISING UTILIZATION OF MICROARRAYS FOR CANCER DETECTION TO DRIVE MARKET
  • TABLE 136 GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 137 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 141 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 142 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
• 7.4 OTHER APPLICATIONS
  • TABLE 143 GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 144 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 149 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)

8 GENE EXPRESSION ANALYSIS MARKET, BY END USER

• 8.1 INTRODUCTION
  • TABLE 150 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
• 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.2.1 GROWING FOCUS ON DEVELOPMENT OF TARGETED THERAPIES TO BOOST DEMAND
  • TABLE 151 GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 152 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 153 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 155 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 156 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 157 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.3 ACADEMIC & RESEARCH INSTITUTES
  • 8.3.1 INCREASING GOVERNMENT-FUNDED INVESTMENTS TO PROPEL MARKET
  • TABLE 158 GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 159 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 160 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 162 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 163 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 164 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• 8.4 OTHER END USERS
  • TABLE 165 GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 166 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 169 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 170 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 171 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)

9 GENE EXPRESSION ANALYSIS MARKET, BY REGION

• 9.1 INTRODUCTION
  • TABLE 172 GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022-2029 (USD MILLION)
• 9.2 NORTH AMERICA
  • FIGURE 31 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT
  • TABLE 173 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 174 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 175 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 176 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 180 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2.1 NORTH AMERICA: RECESSION IMPACT
  • 9.2.2 US
    • 9.2.2.1 Rising expenditure on NGS-based research to drive market
  • TABLE 181 US: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 182 US: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 183 US: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 US: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 185 US: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 US: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 187 US: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2.3 CANADA
    • 9.2.3.1 Increasing incidence of chronic diseases to drive market
  • TABLE 188 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 189 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 190 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 192 CANADA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 194 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.3 EUROPE
  • TABLE 195 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 196 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 197 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 202 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.1 EUROPE: RECESSION IMPACT
  • 9.3.2 GERMANY
    • 9.3.2.1 Rising investments in proteomics & genomics research to drive market
  • TABLE 203 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 204 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 207 GERMANY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 208 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 209 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.3 UK
    • 9.3.3.1 Favorable government support for genomic research projects to fuel market
  • TABLE 210 UK: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 211 UK: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 UK: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 UK: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 UK: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 215 UK: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 216 UK: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.3.4 FRANCE
    • 9.3.4.1 Increasing R&D in life sciences research to fuel market
  • TABLE 217 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 218 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 219 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 221 FRANCE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 223 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)

• 9.3.5 ITALY
  • 9.3.5.1 Favorable government support for industry-academia collaborations to support market growth
• TABLE 224 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 225 ITALY: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 226 ITALY: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 227 ITALY: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 228 ITALY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 229 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 230 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.3.6 SPAIN
  • 9.3.6.1 Growth in biomedical research to boost demand
• TABLE 231 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 232 SPAIN: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 233 SPAIN: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 234 SPAIN: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 235 SPAIN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 236 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 237 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.3.7 REST OF EUROPE
• TABLE 238 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
• TABLE 239 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 240 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 241 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 242 REST OF EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 243 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 244 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.4 ASIA PACIFIC
  • FIGURE 32 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT
  • TABLE 245 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 251 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 252 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
  • 9.4.2 CHINA
    • 9.4.2.1 Rising incidence of infectious diseases to boost demand
  • TABLE 253 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 254 CHINA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 255 CHINA GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 CHINA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 CHINA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 259 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.3 JAPAN
    • 9.4.3.1 Rising technological advancements in sequencing systems to propel market
  • TABLE 260 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 261 JAPAN: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 262 JAPAN: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 263 JAPAN: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 JAPAN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 265 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 266 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.4 INDIA
    • 9.4.4.1 Robust growth in biopharmaceutical industry to drive market
  • TABLE 267 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 268 INDIA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 269 INDIA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 INDIA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 271 INDIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 273 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Increasing focus on R&D expenditure to drive market
  • TABLE 274 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 275 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 276 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 277 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 278 AUSTRALIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 279 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 280 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Rising prevalence of chronic diseases to boost demand
  • TABLE 281 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 282 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 283 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 284 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 285 SOUTH KOREA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 286 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 287 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.4.7 REST OF ASIA PACIFIC
  • TABLE 288 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 289 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 290 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 291 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 292 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 293 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 294 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.5 LATIN AMERICA
  • TABLE 295 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 296 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 297 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 298 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 299 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 300 LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 301 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 302 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.5.1 LATIN AMERICA: RECESSION IMPACT
  • 9.5.2 BRAZIL
    • 9.5.2.1 Growth in biopharmaceutical industry to support market
  • TABLE 303 BRAZIL: GENE EXPRESSION ANALYSIS MARKET BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 304 BRAZIL: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 305 BRAZIL: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 306 BRAZIL: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 307 BRAZIL: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 308 BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 309 BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.5.3 MEXICO
    • 9.5.3.1 Increasing incidence of diabetes and growing geriatric population to propel market
  • TABLE 310 MEXICO: GENE EXPRESSION ANALYSIS MARKET BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 311 MEXICO: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 312 MEXICO: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 313 MEXICO: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 314 MEXICO: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 315 MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 316 MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.5.4 REST OF LATIN AMERICA
  • TABLE 317 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 318 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 319 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 320 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 321 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 322 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 323 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.6 MIDDLE EAST
  • TABLE 324 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 325 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 326 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 327 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 328 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 329 MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 330 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 331 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.6.1 MIDDLE EAST: RECESSION IMPACT
  • 9.6.2 GCC COUNTRIES
  • TABLE 332 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 333 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 334 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 335 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 336 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 337 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 338 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 339 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 9.6.2.1 Saudi Arabia
      • 9.6.2.1.1 Increasing investments in pharmaceutical R&D to support market growth
  • TABLE 340 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 341 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 342 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 343 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 344 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 345 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 346 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 9.6.2.2 United Arab Emirates
      • 9.6.2.2.1 Growing R&D expenditure and advanced healthcare infrastructure to fuel market
  • TABLE 347 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 348 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 349 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 350 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 351 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 352 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 353 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 9.6.2.3 Other GCC Countries
  • TABLE 354 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 355 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 356 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 357 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 358 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 359 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 360 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.6.3 REST OF MIDDLE EAST
  • TABLE 361 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 362 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 363 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 364 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 365 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 366 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 367 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
• 9.7 AFRICA
  • 9.7.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
  • TABLE 368 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • TABLE 369 AFRICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 370 AFRICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 371 AFRICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 372 AFRICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 373 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 374 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.7.2 AFRICA: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
  • FIGURE 33 GENE EXPRESSION ANALYSIS: STRATEGIES DEPLOYED BY GENE EXPRESSION ANALYSIS PLAYERS
• 10.3 REVENUE SHARE ANALYSIS
  • FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS (2021-2023)
• 10.4 MARKET SHARE ANALYSIS
  • FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
  • TABLE 375 GENE EXPRESSION ANALYSIS MARKET: INTENSITY OF COMPETITIVE RIVALRY
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • FIGURE 36 GENE EXPRESSION ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • 10.5.5 COMPANY FOOTPRINT ANALYSIS
  • FIGURE 37 GENE EXPRESSION ANALYSIS MARKET: COMPANY FOOTPRINT (2023)
  • TABLE 376 GENE EXPRESSION ANALYSIS MARKET: TYPE FOOTPRINT
  • TABLE 377 GENE EXPRESSION ANALYSIS MARKET: REGIONAL FOOTPRINT
• 10.6 COMPANY EVALUATION MATRIX: START-UP/SME PLAYERS
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 STARTING BLOCKS
  • 10.6.3 RESPONSIVE COMPANIES
  • 10.6.4 DYNAMIC COMPANIES
  • FIGURE 38 GENE EXPRESSION ANALYSIS MARKET: START-UP/SME EVALUATION MATRIX (2023)
• 10.7 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
  • TABLE 378 GENE EXPRESSION ANALYSIS MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 379 GENE EXPRESSION ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
• 10.8 VALUATION AND FINANCIAL METRICS OF GENE EXPRESSION ANALYSIS VENDORS
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• 10.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 10.9.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL
  • FIGURE 41 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL
• 10.10 COMPETITIVE SCENARIO
  • 10.10.1 PRODUCT LAUNCHES
  • TABLE 380 GENE EXPRESSION ANALYSIS MARKET: PRODUCT LAUNCHES (JANUARY 2021-JANUARY 2024)
  • 10.10.2 DEALS
  • TABLE 381 GENE EXPRESSION ANALYSIS MARKET: DEALS (JANUARY 2021-JANUARY 2024)
  • 10.10.3 EXPANSIONS
  • TABLE 382 GENE EXPRESSION ANALYSIS MARKET: EXPANSIONS (JANUARY 2021-JANUARY 2024)
  • 10.10.4 OTHER DEVELOPMENTS
  • TABLE 383 GENE EXPRESSION ANALYSIS: OTHER DEALS/DEVELOPMENTS (JANUARY 2021-JANUARY 2024)

11 COMPANY PROFILES

• (Business overview, Products/Services offered, Recent developments & MnM View)**
• 11.1 KEY PLAYERS
  • 11.1.1 THERMO FISHER SCIENTIFIC INC.
  • TABLE 384 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • FIGURE 42 THERMOFISHER SCIENTIFIC INC: COMPANY SNAPSHOT (2022)
  • TABLE 385 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 386 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
  • TABLE 387 THERMO FISHER SCIENTIFIC INC.: DEALS
  • 11.1.2 BIO-RAD LABORATORIES, INC.
  • TABLE 388 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
  • TABLE 389 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 390 BIO-RAD LABORATORIES, INC.: DEALS
  • 11.1.3 ILLUMINA, INC.
  • TABLE 391 ILLUMINA, INC.: COMPANY OVERVIEW
  • FIGURE 44 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
  • TABLE 392 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 393 ILLUMINA, INC.: OTHER DEVELOPMENTS
  • 11.1.4 QIAGEN
  • TABLE 394 QIAGEN: COMPANY OVERVIEW
  • FIGURE 45 QIAGEN: COMPANY SNAPSHOT (2022)
  • TABLE 395 QIAGEN: PRODUCTS/SERVICES OFFERED
  • TABLE 396 QIAGEN: PRODUCT LAUNCHES
  • TABLE 397 QIAGEN: DEALS
  • 11.1.5 F. HOFFMANN-LA ROCHE LTD.
  • TABLE 398 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • FIGURE 46 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
  • TABLE 399 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 400 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES
  • 11.1.6 REVVITY
  • TABLE 401 REVVITY: COMPANY OVERVIEW
  • FIGURE 47 REVVITY: COMPANY SNAPSHOT (2022)
  • TABLE 402 REVVITY: PRODUCTS/SERVICES OFFERED
  • TABLE 403 REVVITY: PRODUCT LAUNCHES
  • TABLE 404 REVVITY: DEALS
  • TABLE 405 REVVITY: OTHER DEVELOPMENTS
  • 11.1.7 PACBIO
  • TABLE 406 PACBIO: COMPANY OVERVIEW
  • FIGURE 48 PACBIO: COMPANY SNAPSHOT (2022)
  • TABLE 407 PACBIO: PRODUCTS/SERVICES OFFERED
  • TABLE 408 PACBIO: PRODUCT LAUNCHES
  • TABLE 409 PACBIO: DEALS
  • TABLE 410 PACBIO: OTHER DEVELOPMENTS
  • 11.1.8 AGILENT TECHNOLOGIES, INC.
  • TABLE 411 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • FIGURE 49 AGILENT TECHNOLOGIES, INC: COMPANY SNAPSHOT (2023)
  • TABLE 412 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 413 AGILENT TECHNOLOGIES, INC.: DEALS
  • TABLE 414 AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS
  • 11.1.9 SYSMEX CORPORATION
  • TABLE 415 SYSMEX CORPORATION: COMPANY OVERVIEW
  • FIGURE 50 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)
  • TABLE 416 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 417 SYSMEX CORPORATION: DEALS
  • TABLE 418 SYSMEX CORPORATION: OTHER DEVELOPMENTS
  • 11.1.10 BGI
  • TABLE 419 BGI: COMPANY OVERVIEW
  • TABLE 420 BGI: PRODUCTS/SERVICES OFFERED
  • TABLE 421 BGI: DEALS
  • 11.1.11 EUROFINS SCIENTIFIC SE
  • TABLE 422 EUROFINS SCIENTIFIC SE: COMPANY OVERVIEW
  • FIGURE 51 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2022)
  • TABLE 423 EUROFINS SCIENTIFIC SE: PRODUCTS/SERVICES OFFERED
  • TABLE 424 EUROFINS SCIENTIFIC SE: OTHER DEVELOPMENTS
  • 11.1.12 STANDARD BIOTOOLS
  • TABLE 425 STANDARD BIOTOOLS: COMPANY OVERVIEW
  • FIGURE 52 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2022)
  • TABLE 426 STANDARD BIOTOOLS: PRODUCTS/SERVICES OFFERED
  • TABLE 427 STANDARD BIOTOOLS: PRODUCT LAUNCHES
  • 11.1.13 OXFORD NANOPORE TECHNOLOGIES PLC
  • TABLE 428 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
  • TABLE 429 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED
  • TABLE 430 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS
  • 11.1.14 GENSCRIPT
  • TABLE 431 GENSCRIPT: COMPANY OVERVIEW
  • FIGURE 53 GENSCRIPT: COMPANY SNAPSHOT
  • TABLE 432 GENSCRIPT: PRODUCTS/SERVICES OFFERED
  • TABLE 433 GENSCRIPT: OTHER DEVELOPMENTS
  • 11.1.15 TAKARA BIO INC.
  • TABLE 434 TAKARA BIO INC.: COMPANY OVERVIEW
  • FIGURE 54 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
  • TABLE 435 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 436 TAKARA BIO INC.: PRODUCT LAUNCHES
• *Details on Business overview, Products/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
• 11.2 OTHER PLAYERS
  • 11.2.1 10X GENOMICS INC.
  • 11.2.2 ZYMO RESEARCH CORPORATION
  • 11.2.3 TWIST BIOSCIENCE
  • 11.2.4 PROMEGA CORPORATION
  • 11.2.5 LGC LIMITED
  • 11.2.6 CD GENOMICS
  • 11.2.7 NANOSTRING TECHNOLOGIES, INC.
  • 11.2.8 BIOSPYDER, INC
  • 11.2.9 INTEGRATED DNA TECHNOLOGIES, INC.
  • 11.2.10 NEW ENGLAND BIOLABS, INC.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

관련자료